- Presentations
- 4
- Markets
- 1
Trileptal is a brand of Oxcarbazepine marketed by Novartis Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Oxcarbazepine
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 60 mg/mL oral suspension, 150 mg tablet, 300 mg tablet, 600 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Trileptal 60 mg/mL oral suspensionOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Trileptal 150 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Trileptal 300 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Trileptal 600 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Oxcarbazepine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Trileptal
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.